Back to Search
Start Over
Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion.
- Source :
-
Leukemia research [Leuk Res] 2011 Sep; Vol. 35 (9), pp. e175-6. Date of Electronic Publication: 2011 Jun 11. - Publication Year :
- 2011
- Subjects :
- Antineoplastic Agents therapeutic use
Cytogenetic Analysis
Hematologic Tests
Humans
Lenalidomide
Remission Induction
Thalidomide therapeutic use
Time Factors
Treatment Outcome
Chromosome Deletion
Chromosomes, Human, Pair 5 genetics
Myelodysplastic Syndromes blood
Myelodysplastic Syndromes drug therapy
Myelodysplastic Syndromes genetics
Thalidomide analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 1873-5835
- Volume :
- 35
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Leukemia research
- Publication Type :
- Report
- Accession number :
- 21658768
- Full Text :
- https://doi.org/10.1016/j.leukres.2011.05.020